Related Experiment Video
Updated: Apr 13, 2026
03:52
The Creation of a Rat Model for Osteosarcopenia via Ovariectomy
Published on: February 21, 2025
1.5K
Sarcopenia in chronic kidney disease
Viviane Angelina de Souza1, Dílmerson de Oliveira1, Henrique Novais Mansur2
1Universidade Federal de Juiz de Fora, Brasil.
Jornal Brasileiro De Nefrologia
|April 30, 2015
Summary
Sarcopenia, a loss of muscle mass and strength, is common in Chronic Kidney Disease (CKD). Early recognition and intervention are crucial to manage this condition and its associated health risks in CKD patients.
Area of Science:
- Gerontology
- Nephrology
- Muscle Physiology
Background:
- Sarcopenia, characterized by reduced muscle mass, strength, and function, is linked to physiological aging.
- In Chronic Kidney Disease (CKD), sarcopenia is highly prevalent, contributing to increased morbidity, mortality, and cardiovascular complications.
Purpose of the Study:
- To analyze the complex mechanisms underlying muscle mass loss in patients with renal insufficiency.
- To highlight the importance of early sarcopenia recognition in CKD patients for timely therapeutic interventions.
Main Methods:
- Analysis of contributing factors to muscle wasting in CKD patients.
- Review of current therapeutic strategies for sarcopenia in the context of renal insufficiency.
Main Results:
- Identified key mechanisms driving sarcopenia in CKD, including ubiquitin-proteasome system activation, inflammation, metabolic acidosis, angiotensin II, and hormonal factors.
- Outlined therapeutic approaches such as exercise, correction of metabolic acidosis, hormone replacement, and managing insulin resistance.
Conclusions:
- Early identification of sarcopenia in CKD is essential for effective treatment.
- Interventions can mitigate complications associated with muscle wasting in CKD, improving patient outcomes.
Related Concept Videos
01:28Chronic Kidney Disease III: Interprofessional Care
645
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
645
01:24Chronic Kidney Disease II: Clinical Manifestations
1.0K
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
1.0K
01:25Chronic Kidney Disease I: Introduction
1.2K
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
1.2K
01:21Overview of Protein Metabolism
4.8K
Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
4.8K
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
329
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
329
01:29Acute Kidney Injury II: Pathophysiology
2.0K
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
2.0K